A Study of LY3305677 in Participants With Type 2 Diabetes

Clinical trial NCT03928379 · COMPLETED

Trial details

NCT number: NCT03928379
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2019-10-27
Primary completion: 2021-07-08
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.